posted on 2024-06-28, 13:38authored byWen-Kai Liu, Bing-Mei Su, Xin-Qi Xu, Lian Xu, Juan Lin
Hydroxytyrosol, a naturally occurring
compound with antioxidant
and antiviral activity, is widely applied in the cosmetic, food, and
nutraceutical industries. The development of a biocatalytic approach
for producing hydroxytyrosol from simple and readily accessible substrates
remains a challenge. Here, we designed and implemented an effective
biocatalytic cascade to obtain hydroxytyrosol from 3,4-dihydroxybenzaldehyde
and l-threonine via a four-step enzymatic cascade composed
of seven enzymes. To prevent cross-reactions and protein expression
burden caused by multiple enzymes expressed in a single cell, the
designed enzymatic cascade was divided into two modules and catalyzed
in a stepwise manner. The first module (FM) assisted the assembly
of 3,4-dihydroxybenzaldehyde and l-threonine into (2S,3R)-2-amino-3-(3,4-dihydroxyphenyl)-3-hydroxypropanoic
acid, and the second module (SM) entailed converting (2S,3R)-2-amino-3-(3,4-dihydroxyphenyl)-3-hydroxypropanoic
acid into hydroxytyrosol. Each module was cloned into Escherichia coli BL21 (DE3) and engineered in parallel
by fine-tuning enzyme expression, resulting in two engineered whole-cell
catalyst modules, BL21(FM01) and BL21(SM13), capable of converting
30 mM 3,4-dihydroxybenzaldehyde to 28.7 mM hydroxytyrosol with a high
space–time yield (0.88 g/L/h). To summarize, the current study
proposes a simple and effective approach for biosynthesizing hydroxytyrosol
from low-cost substrates and thus has great potential for industrial
applications.